Recursion Pharmaceuticals, Inc. (RXRX)
3.245
-0.26
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
+0.02
(+0.46%)
After-Hours: 20:00
Recursion Pharmaceuticals Price : 3.245 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 3.39 | 3.630 | 3.37 | 3.50 | 22.90M |
| Aug 20, 2026 | 3.40 | 3.46 | 3.27 | 3.34 | 21.45M |
| Aug 19, 2026 | 3.275 | 3.50 | 3.19 | 3.50 | 30.37M |
| Aug 18, 2026 | 3.03 | 3.10 | 2.92 | 3.09 | 16.35M |
| Aug 17, 2026 | 3.12 | 3.16 | 3.08 | 3.11 | 10.62M |
| Aug 14, 2026 | 3.30 | 3.305 | 3.14 | 3.16 | 10.55M |
| Aug 13, 2026 | 3.31 | 3.35 | 3.27 | 3.31 | 10.70M |
| Aug 12, 2026 | 3.37 | 3.38 | 3.26 | 3.29 | 10.31M |
| Aug 11, 2026 | 3.32 | 3.42 | 3.27 | 3.35 | 11.01M |
| Aug 10, 2026 | 3.20 | 3.36 | 3.19 | 3.29 | 14.03M |
| Aug 07, 2026 | 3.254 | 3.265 | 3.18 | 3.22 | 9.356M |
| Aug 06, 2026 | 3.13 | 3.26 | 3.115 | 3.18 | 14.79M |
| Aug 05, 2026 | 3.08 | 3.23 | 3.01 | 3.17 | 17.46M |
| Aug 04, 2026 | 3.265 | 3.36 | 3.21 | 3.31 | 21.58M |
| Aug 03, 2026 | 3.03 | 3.20 | 3.00 | 3.18 | 14.72M |
| Jul 31, 2026 | 3.09 | 3.105 | 2.95 | 3.00 | 15.33M |
| Jul 30, 2026 | 2.99 | 3.04 | 2.95 | 3.04 | 10.41M |
| Jul 29, 2026 | 3.03 | 3.09 | 2.945 | 2.97 | 17.95M |
| Jul 28, 2026 | 2.975 | 3.05 | 2.86 | 3.05 | 24.40M |
| Jul 27, 2026 | 3.03 | 3.13 | 2.99 | 3.01 | 21.72M |
| Jul 24, 2026 | 3.04 | 3.09 | 2.92 | 2.96 | 16.53M |
| Jul 23, 2026 | 2.925 | 3.03 | 2.92 | 3.01 | 18.83M |
| Jul 22, 2026 | 3.04 | 3.07 | 2.97 | 2.98 | 15.21M |
| Jul 21, 2026 | 2.90 | 3.08 | 2.90 | 3.08 | 14.87M |
| Jul 20, 2026 | 2.945 | 2.955 | 2.84 | 2.89 | 20.81M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 140.74 |
| Absci Corp. | 8.855 |
| Novavax, Inc. | 8.855 |
| Editas Medicine, Inc. | 3.00 |
| Dyne Therapeutics, Inc. | 26.00 |
Price Related Metrics
| PS Ratio | 30.10 |
| Price to Book Value | 1.894 |
| Earnings Yield | -31.94% |
| Market Cap | 1.733B |